Search details
1.
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Breast Cancer Res Treat
; 2024 May 04.
Article
in English
| MEDLINE | ID: mdl-38703285
2.
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.
EClinicalMedicine
; 71: 102520, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38638399
3.
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer.
Breast
; 71: 42-46, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37481795
4.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Nat Commun
; 14(1): 1157, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36859416
5.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Front Oncol
; 13: 1151496, 2023.
Article
in English
| MEDLINE | ID: mdl-37188177
6.
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis.
Cancer Treat Rev
; 104: 102352, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35144055
7.
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cancer Treat Rev
; 106: 102392, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35436729
8.
Gene expression profiles of breast cancer metastasis according to organ site.
Mol Oncol
; 16(1): 69-87, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34051058
9.
The role of CDK4/6 inhibitors in early breast cancer.
Breast
; 58: 160-169, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34087775
10.
Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review.
J Breast Cancer
; 22(4): 661-666, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31897340
11.
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer.
Clin Cancer Res
; 25(5): 1639-1649, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30504425
Results
1 -
11
de 11
1
Next >
>>